|
1. Chen LH, Lo WC, Huang HY, Wu HM. A Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment. Int J Mol Sci 2023; 24:7503. doi: 10.3390/ijms24087503. 2. Monnin N, Fattet AJ, Koscinski I. Endometriosis: Update of Pathophysiology, (Epi) Genetic and Environmental Involvement. Biomedicines 2023; 11:978. doi: 10.3390/biomedicines11030978. 3. Allaire C, Bedaiwy MA, Yong PJ. Diagnosis and management of endometriosis. CMAJ 2023;195:E363-E371. doi : 10.1503/cmaj.220637. 4. Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, Ramirez-Acuña JM, Perez-Romero BA, Guerrero-Rodriguez JF, et al. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases. Int J Mol Sci 2020;21:9739. doi : 10.3390/ijms21249739. 5. Cui N, Hu M, Khalil RA. Biochemical and Biological Attributes of Matrix Metalloproteinases. Prog Mol Biol Transl Sci 2017;147:1-73. doi: 10.1016/bs.pmbts.2017.02.005. 6. Czyzyk A, Podfigurna A, Szeliga A, Meczekalski B. Update on endometriosis pathogenesis. Minerva Ginecol 2017;69:447-61. doi: 10.23736/S0026-4784.17.04048-5. 7. Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am 2012;39:535-49. doi: 10.1016/j.ogc.2012.10.002. 8. Gaide Chevronnay HP, Selvais C, Emonard H, Galant C, Marbaix E, Henriet P. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration. Biochim Biophys Acta 2012;1824:146-56. doi: 10.1016/j.bbapap.2011.09.003. 9. Mousazadeh S, Ghaheri A, Shahhoseini M, Aflatoonian R, Afsharian P. The Effect of Imbalanced Progesterone Receptor-A/-B Ratio on Gelatinase Expressions in Endometriosis. Int J Fertil Steril 2019;13:127-34. doi: 10.22074/ijfs.2019.5604. 10. Vandooren J, Van den Steen PE, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade. Crit Rev Biochem Mol Biol 2013;48:222-72. doi: 10.3109/10409238.2013.770819. 11. Yang WJ, Liu FC, Hsieh JS, Chen CH, Hsiao SY, Lin CS. Matrix metalloproteinase 2 level in human follicular fluid is a reliable marker of human oocyte maturation in in vitro fertilization and intracytoplasmic sperm injection cycles. Reprod Biol Endocrinol 2015;13:102. doi: 10.1186/s12958-015-0099-8. 12. Hadler-Olsen E, Fadnes B, Sylte I, Uhlin-Hansen L, Winberg JO. Regulation of matrix metalloproteinase activity in health and disease. FEBS J 2011;278:28-45. doi: 10.1111/j.1742-4658.2010.07920. x. 13. Chung HW, Wen Y, Chun SH, Nezhat C, Woo BH, Lake Polan M. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness. Fertil Steril 2001;75:152-9. doi: 10.1016/s0015-0282(00)01670-8. 14. Huang H. Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances. Sensors 2018;18:3249. doi: 10.3390/s18103249. 15. Yuan M, Zhan Q, Duan X, Song B, Zeng S, Chen X, et al. A functional polymorphism at miR-491-5p binding site in the 3'-UTR of MMP-9 gene confers increased risk for atherosclerotic cerebral infarction in a Chinese population. Atherosclerosis 2013;226:447-52. doi: 10.1016/j.atherosclerosis.2012.11.026. 16. Tsai EM, Wang YS, Lin CS, Lin WY, Hsi E, Wu MT, et al. A microRNA-520 mirSNP at the MMP2 gene influences susceptibility to endometriosis in Chinese women. J Hum Genet 2013;58:202-9. doi: 10.1038/jhg.2013.1. 17. Collins A, Ke X. Primer1: primer design web service for tetra-primer ARMS-PCR. Open Bioinform J 2012;6:55-8. doi: 10.2174/1875036201206010055. 18. Curry TE Jr, Osteen KG. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 2003;24:428-65. doi: 10.1210/er.2002-0005. 19. Gaide Chevronnay HP, Selvais C, Emonard H, Galant C, Marbaix E, Henriet P. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration. Biochim Biophys Acta 2012; 1824:146-56. doi: 10.1016/j.bbapap.2011.09.003. 20. Nagyová E, Němcová L, Camaioni A. Cumulus Extracellular Matrix Is an Important Part of Oocyte Microenvironment in Ovarian Follicles: Its Remodeling and Proteolytic Degradation. Int J Mol Sci 2021; 23:54. doi: 10.3390/ijms23010054. 21. Mousazadeh S, Ghaheri A, Shahhoseini M, Aflatoonian R, Afsharian P. The Effect of Imbalanced Progesterone Receptor-A/-B Ratio on Gelatinase Expressions in Endometriosis. Int J Fertil Steril 2019; 13:127-34. doi: 10.22074/ijfs.2019.5604. 22. Tapia-Pizarro A, Figueroa P, Brito J, Marín JC, Munroe DJ, Croxatto HB. Endometrial gene expression reveals compromised progesterone signaling in women refractory to embryo implantation. Reprod Biol Endocrinol 2014; 12:92. doi: 10.1186/1477-7827-12-92. 23. McCord LA, Li F, Rosewell KL, Brännström M, Curry TE. Ovarian expression and regulation of the stromelysins during the periovulatory period in the human and the rat. Biol Reprod 2012; 86:78. doi: 10.1095/biolreprod.111.095588. 24. Qiu X, Xie Y, Chen L, Gemzell-Danielsson K. Expression of matrix metalloproteinases and their inhibitors at the feto-maternal interface in unruptured ectopic tubal pregnancy. Acta Obstet Gynecol Scand 2011; 90:966-71. doi: 10.1111/j.1600-0412.2011.01206. x. 25. Xie Y, Mustafa A, Yerzhan A, Merzhakupova D, Yerlan P, et al. nuclear matrix metalloproteinases: functions resemble the evolution from the intracellular to the extracellular compartment. Cell Death Discov 2017;3:17036. doi: 10.1038/cddiscovery.2017.36. 26. Skrzypczak J, Wirstlein P, Mikołajczyk M, Ludwikowski G, Zak T. TGF superfamily and MMP2, MMP9, TIMP1 genes expression in the endometrium of women with impaired reproduction. Folia Histochem Cytobiol 2007;45 Suppl 1:S143-8. 27. Zahrah A, Muharam R, Satria Marwali ML, Ocktariyana, Deraya IE, Asmarinah. mRNA expression and DNA methylation level of the MMP-2 gene in peritoneal endometriosis. J Pak Med Assoc 2021;71(Suppl 2)(2):S112-S115. 28. Chung HW, Lee JY, Moon HS, Hur SE, Park MH, Wen Y, et al. Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil Steril 2002;78:787-95. doi: 10.1016/s0015-0282(02)03322-8. 29. Sillem M, Prifti S, Koch A, Neher M, Jauckus J, Runnebaum B. Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis. Eur J Obstet Gynecol Reprod Biol 2001;95:167-74. doi: 10.1016/s0301-2115(00)00415-2. 30. Liu H, Wang J, Wang H, Tang N, Li Y, Zhang Y, et al. Correlation between matrix metalloproteinase-9 and endometriosis. Int J Clin Exp Pathol 2015;8:13399-404. 31. Singh R, Srivastava P, Srivastava A, Mittal RD. Matrix metalloproteinase (MMP-9 and MMP-2) gene polymorphisms influence allograft survival in renal transplant recipients. Nephrol Dial Transplant 2010;25:3393-401. doi: 10.1093/ndt/gfq174. 32. Arablou T, Aryaeian N, Khodaverdi S, Kolahdouz-Mohammadi R, Moradi Z, Rashidi N, et al. The effects of resveratrol on the expression of VEGF, TGF-β, and MMP-9 in endometrial stromal cells of women with endometriosis. Sci Rep 2021;11:6054. doi: 10.1038/s41598-021-85512-y. 33. Stephens S, Seto MC, Goodwill AM, Cantor JM. The Relationships Between Victim Age, Gender, and Relationship Polymorphism and Sexual Recidivism. Sex Abuse 2018;30:132-46. doi: 10.1177/1079063216630983.
|
